Skip to main content
Erschienen in: BMC Pregnancy and Childbirth 1/2023

Open Access 01.12.2023 | Matters Arising

Comment on: “Do maternal albumin levels affect post-operative complications after cesarean delivery?”

verfasst von: Shuangqiong Zhou, Xiuhong Cao, Zhiqiang Liu

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2023

Abstract

Hypoalbuminemia is often considered an independent risk factor for surgical site infections. This study first demonstrated that albumin level ≥ 3.3 g/dL was independently associated with adverse maternal outcomes. In this letter to the editor, we would like to raise some concerns about the study and clarify the interpretation of the results.
Hinweise
the first to. Analyze the relationship between maternal serum albumin levels before elective cesarean delivery (CD) and postoperative complications.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Main text

Surgical site infection (SSI) is a major cause of prolonged hospital stay and a burden to the healthcare system [1, 2]. Maternal SSI after cesarean delivery is a clinical problem that contributes to significant morbidity and mortality rates. We read with great interest the study by Yagur et al., who published a retrospective cohort study, the first to analyze the relationship between maternal serum albumin levels before elective cesarean delivery (CD) and postoperative complications [3]. The results suggested that high serum albumin levels among women undergoing CD might be associated with abnormal postoperative outcomes. However, the results of the study were unexpected; based on these results, it can be hypothesized that changes in serum albumin level, especially increases from the normal range, may affect maternal pregnancy outcomes.
In this retrospective cohort study, many risk factors for SSI were included, However, many other relevant variables likely were not measured. Since both groups differed significantly across measured variables at admission, it is likely that unmeasured variables were similarly unbalanced. We think it is too early to come to the conclusion and offer the following points as counter-argument.
First, in this article, parturients with preeclampsia were excluded from the study. Tran et al. [4] found that preeclampsia was an independent risk factor for SSI. Preeclampsia is often associated with hypoalbuminemia. Thus, the exclusion of women with preeclampsia may influence the results.
Second, risk factors such as surgery duration, [5] hypertension disorders, [6] and blood transfusion during CD were not included. Prolonged operative time has been shown to increase the risk of SSI [7]. Furthermore, hypertensive disorder is an independent risk factor for wound infection after CD [6]. In a hospital-based case-control study, blood transfusion during or following delivery, was shown to be an independent risk factor for SSI [8]. Mazzeffi et al. declared that RBC transfusion may be associated with increased risk for organ space SSI and septic shock after colon resection surgery [9].
Third, obesity, especially pregestational obesity, as a potential risk for post-CD wound infection has been discussed previously [46, 1012]. Maternal obesity (body mass index (BMI) ≥ 30 kg/m2) was significantly linked to an increased incidence of SSI. While pregestational BMI was not included in the article, delivery BMI was divided into BMI < 25 kg/m2 and BMI ≥ 25 kg/m2. Thus, the proportion of BMI > 30 kg/m2 was not compared between the two groups. Furthermore, other factors such as incision length > 16.6 cm [10] and subcutaneous tissue thickness > 3 cm, [13] that have a great effect on the risk of developing SSI were not considered. Diabetes mellitus was included in this study, but it was unclear whether this was gestational diabetes mellitus, which could have affected the results.
Finally, we have a few concerns regarding the methodology of this study. First, a receiver operating characteristic (ROC) curve was generated, and a cutoff value of 3.3 g/dL was provided in this study. However, the ROC curve was not presented and neither the value of sensitivity, specificity, nor the area under the ROC curve and its 95% confidence interval were described. Secondly, the presented regression is composed of many variables, but there is no explanation why these variables were entered as no description of the groups is presented. As this study was to analyze whether high serum albumin levels among women undergoing CD affect risks of postoperative outcomes, a case-control study may be more appropriate which begins with an outcome to comprehend the cause.
In conclusion, many details about the course of deliveries are unavailable in this study. The result may only be convincing after accounting for these confounding factors. There are multiple possible causes of SSI that the study does not address.

Acknowledgements

Not applicable.

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
the first to. Analyze the relationship between maternal serum albumin levels before elective cesarean delivery (CD) and postoperative complications.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site infection, 2017. JAMA Surg. 2017;152(8):784–91.CrossRefPubMed Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site infection, 2017. JAMA Surg. 2017;152(8):784–91.CrossRefPubMed
2.
Zurück zum Zitat Borchardt RA, Tzizik D. Update on surgical site infections: the new CDC guidelines. JAAPA. 2018;31(4):52–4.CrossRefPubMed Borchardt RA, Tzizik D. Update on surgical site infections: the new CDC guidelines. JAAPA. 2018;31(4):52–4.CrossRefPubMed
3.
Zurück zum Zitat Yagur Y, Ribak R, Ben Ezry E, Cohen I, Or Madar L, Kovo M, et al. Do maternal albumin levels affect post-operative complications after cesarean delivery? BMC Pregnancy Childbirth. 2022;22(1):909.CrossRefPubMedPubMedCentral Yagur Y, Ribak R, Ben Ezry E, Cohen I, Or Madar L, Kovo M, et al. Do maternal albumin levels affect post-operative complications after cesarean delivery? BMC Pregnancy Childbirth. 2022;22(1):909.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Tran TS, Jamulitrat S, Chongsuvivatwong V, Geater A. Risk factors for postcesarean surgical site infection. Obstet Gynecol. 2000;95(3):367–71.PubMed Tran TS, Jamulitrat S, Chongsuvivatwong V, Geater A. Risk factors for postcesarean surgical site infection. Obstet Gynecol. 2000;95(3):367–71.PubMed
5.
Zurück zum Zitat Opøien HK, Valbø A, Grinde-Andersen A, Walberg M. Post-cesarean surgical site infections according to CDC standards: rates and risk factors. A prospective cohort study. Acta Obstet Gynecol Scand. 2007;86(9):1097–102.CrossRefPubMed Opøien HK, Valbø A, Grinde-Andersen A, Walberg M. Post-cesarean surgical site infections according to CDC standards: rates and risk factors. A prospective cohort study. Acta Obstet Gynecol Scand. 2007;86(9):1097–102.CrossRefPubMed
6.
Zurück zum Zitat Schneid-Kofman N, Sheiner E, Levy A, Holcberg G. Risk factors for wound infection following cesarean deliveries. Int J Gynaecol Obstet. 2005;90(1):10–5.CrossRefPubMed Schneid-Kofman N, Sheiner E, Levy A, Holcberg G. Risk factors for wound infection following cesarean deliveries. Int J Gynaecol Obstet. 2005;90(1):10–5.CrossRefPubMed
7.
Zurück zum Zitat Cheng H, Chen BP-H, Soleas IM, Ferko NC, Cameron CG, Hinoul P. Prolonged operative duration increases risk of Surgical Site Infections: a systematic review. Surg Infect (Larchmt). 2017;18(6):722–35.CrossRefPubMed Cheng H, Chen BP-H, Soleas IM, Ferko NC, Cameron CG, Hinoul P. Prolonged operative duration increases risk of Surgical Site Infections: a systematic review. Surg Infect (Larchmt). 2017;18(6):722–35.CrossRefPubMed
8.
Zurück zum Zitat Kvalvik SA, Rasmussen S, Thornhill HF, Baghestan E. Risk factors for surgical site infection following cesarean delivery: a hospital-based case-control study. Acta Obstet Gynecol Scand. 2021;100(12):2167–75.CrossRefPubMed Kvalvik SA, Rasmussen S, Thornhill HF, Baghestan E. Risk factors for surgical site infection following cesarean delivery: a hospital-based case-control study. Acta Obstet Gynecol Scand. 2021;100(12):2167–75.CrossRefPubMed
9.
Zurück zum Zitat Mazzeffi M, Tanaka K, Galvagno S. Red Blood Cell Transfusion and Surgical Site infection after Colon resection surgery: a Cohort Study. Anesth Analg. 2017;125(4):1316–21.CrossRefPubMed Mazzeffi M, Tanaka K, Galvagno S. Red Blood Cell Transfusion and Surgical Site infection after Colon resection surgery: a Cohort Study. Anesth Analg. 2017;125(4):1316–21.CrossRefPubMed
10.
Zurück zum Zitat De Vivo A, Mancuso A, Giacobbe A, Priolo AM, De Dominici R, Maggio Savasta L. Wound length and corticosteroid administration as risk factors for surgical-site complications following cesarean section. Acta Obstet Gynecol Scand. 2010;89(3):355–9.CrossRefPubMed De Vivo A, Mancuso A, Giacobbe A, Priolo AM, De Dominici R, Maggio Savasta L. Wound length and corticosteroid administration as risk factors for surgical-site complications following cesarean section. Acta Obstet Gynecol Scand. 2010;89(3):355–9.CrossRefPubMed
11.
Zurück zum Zitat Wloch C, Wilson J, Lamagni T, Harrington P, Charlett A, Sheridan E. Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG. 2012;119(11):1324–33.CrossRefPubMed Wloch C, Wilson J, Lamagni T, Harrington P, Charlett A, Sheridan E. Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG. 2012;119(11):1324–33.CrossRefPubMed
12.
Zurück zum Zitat Olsen MA, Butler AM, Willers DM, Devkota P, Gross GA, Fraser VJ. Risk factors for surgical site infection after low transverse cesarean section. Infect Control Hosp Epidemiol. 2008;29(6). Olsen MA, Butler AM, Willers DM, Devkota P, Gross GA, Fraser VJ. Risk factors for surgical site infection after low transverse cesarean section. Infect Control Hosp Epidemiol. 2008;29(6).
13.
Zurück zum Zitat Vermillion ST, Lamoutte C, Soper DE, Verdeja A. Wound infection after cesarean: effect of subcutaneous tissue thickness. Obstet Gynecol. 2000;95(6 Pt 1):923–6.PubMed Vermillion ST, Lamoutte C, Soper DE, Verdeja A. Wound infection after cesarean: effect of subcutaneous tissue thickness. Obstet Gynecol. 2000;95(6 Pt 1):923–6.PubMed
Metadaten
Titel
Comment on: “Do maternal albumin levels affect post-operative complications after cesarean delivery?”
verfasst von
Shuangqiong Zhou
Xiuhong Cao
Zhiqiang Liu
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2023
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-023-05756-6

Weitere Artikel der Ausgabe 1/2023

BMC Pregnancy and Childbirth 1/2023 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.